FOLH1 and prostate cancer: The biodistribution of [18F]DCFPyL was determined in nude mice bearing human prostate cancer tumors transfected with PSMA (PC3(+) xenografts) at 30, 60, 90 and 120 min post-injection (Figure 4A,B).